Abstract:Objctives To present the surgical technique of 1470 nm diode laser antegrade enucleation of the prostate for benign prostatic hyperplasia (BPH) and evaluate its clinical efficacy.Methods 30 consecutive patients with BPH who underwent transurethral 1470 nm diode laser antegradeenucleation of the prostate at our institution from September 2016 to January 2017 were reviewed.The mean age of the patients was (72±9) years (range 53 to 86 years),and the prostate volume was (54±25) ml (range 27 to 120 ml).All procedures had been accomplished with antegrade approach:Firstly,two grooves deep into the capsule were created from bladder neck to 1 cm proximalto verumontanum at 5 and 7 o'clock direction.After the median lobe was vaporized,the distal margin of prostate was deepened to the capsule plane and extended to 9 and 3 o'clock position.Then the adenoma at 12 o'clock were vaporized to expose the capsule from the bladder neck to the proximal urethral sphincter.Subsequently,two lateral lobes were enucleated along the capsule with antegrade approach,respectively.The adenoma ＞80 ml were sucked by tissue morcellator and the adenoma ＜80 ml were vaporized segmentally.Results The mean operation time was (65±14) min,and the median estimated blood loss [M(QR)] was 10 (15) ml.The median postoperative hospital stay and mean duration of catheterization were 4 (3.8) d and (4.5±1.5) d (range 2 to 8 d),respectively.Preoperative and postoperative mean hemoglobin and serum sodium concentration were (129±23) versus (125±20) g/L and (141±3) versus (140±3) rnmol/L,respectively,where the differences were not statistically significant.The mean IPSS score,QOL sore and Qmaxpreoperative and 1 month postoperative were (22±6) versus (8± 3),(5.2±0.7) versus (1.9±0.9),and (7.8±2.1) versus (17.2±3.9) ml/s,respectively,with significantly differences.No patient experienced postoperative complications such as incontinence or urethral stricture during a median follow-up of 2.3(2.8) months (range 1 to 4 months).Conclusion Transurethral 1470 nm diode laser antegradeenucleation of the prostate is safe and effective for treatment of BPH which could provide rapid postoperative rehabilitation.

Laser Technology Advancements in the Treatment of Benign Prostatic Hypertrophy

[Laser Techniques in the Treatment of Benign Prostatic Syndrome]

Six Novel Minimally Invasive Therapies for Benign Prostatic Hyperplasia

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation

[Treatment of benign prostatic hyperplasia with the use of lasers]

Which Laser Works Best for Benign Prostatic Hyperplasia?

Advances in lasers for the minimally invasive treatment of upper and lower urinary tract conditions: a systematic review

Advantages and progresses of laser on the treatment of BPH

Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature

Advances in Outpatient Therapies and Treatment of Benign Prostatic Hyperplasia: A Comprehensive Review for Men's Health

Medical Advancements in Benign Prostatic Hyperplasia Treatments

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males

Short-term Effect of 980/1470nm Diode Laser Technology on Benign Prostatic Hyperplasia

Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy

Laser ablation as focal therapy for prostate cancer

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia

Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review

Diode Laser Vaporization for Benign Prostate Hyperplasia: Outcome After 126 Procedures

Contemporary surgical treatment of benign prostatic hyperplasia

Technique and efficacy of 1470 nm diode laser antegradeenucleation of the prostate for benign Prostatic hyperplasia

In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia